I
Immuneering Corp
NASDAQ:IMRX
Immuneering Corp
NASDAQ:IMRX
Price:
1.44 USD
3.6%
Market Closed
Updated:
May 29, 2024
Immuneering Corp
Other
|
Immuneering Corp
Other Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
I
|
Immuneering Corp
NASDAQ:IMRX
|
Other
-$203.8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other
-$527m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other
-$261m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other
-$134m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other
-$290.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other
-$947.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
See Also
What is Immuneering Corp's Other?
Other
-203.8k
USD
-203.8k
USD
Based on the financial report for Dec 31, 2023, Immuneering Corp's Other amounts to -203.8k USD.
What is Immuneering Corp's Other growth rate?
Other CAGR 1Y
27%
27%
Over the last year, the Other growth was 27%.
You don't have any saved screeners yet
